IP Verse

Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi competitive analysis

Latest oppositions filed by Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi

Explore patent oppositions filed by Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026
Patent NumberTitleApplicantOpposition Date
EP3897646
Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025
EP2234617
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 20, 2021
EP2345410
Controlled Release Pharmaceutical CompositionASTELLAS PHARMASep 29, 2021
EP2340828
Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTISApr 7, 2021
EP2962690
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 15, 2019

Latest PTAB cases involving Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi

Discover the latest PTAB cases involving Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanovel Ila Sanayi Ve Ticaret Anonim Sirketi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOVEL ILA SANAYI VE TICARET ANONIM SIRKETI5 - - -
ACTELION PHARMACEUTICALS - 2321
AMGEN EUROPE247 - -
ASTELLAS PHARMA - 40 - 1